Literature DB >> 33958896

Predictors of Anemia Among Adult HIV Positive Patients on First-Line Antiretroviral Therapy in Northwest Ethiopia: A Retrospective Follow-Up Study.

Chilot Desta Agegnehu1, Mehari Woldemariam Merid2, Melaku Kindie Yenit2.   

Abstract

BACKGROUND: Globally, anemia is a common hematological disorder among HIV-infected patients. People with anemia often suffer from impaired physical functioning, psychological distress, and poor quality of life. Therefore, the aim of this study was to determine the incidence of anemia and its determinants among HIV positive individuals in northwest Ethiopia.
METHODS: A total of 486 adult HIV positive patients on the first-line ART with complete information were enrolled in the adult care clinics of northwest Amhara referral hospitals from December 2015 to December 2018. EpiData version 4.2 was used for data entry and Stata version 14 for analysis. Variables having time to event nature were presented with the Kaplan-Meier function. The Cox regression model was used to identify predictors of anemia. Variables with P-values less than 0.2 in the bivariable analysis were considered in the multivariable regression. Adjusted hazard ratio with 95% CI was computed, and variables with less than 0.05 P-values in the multivariable Cox regression were taken as significant predictors of anemia.
RESULTS: This study noted an overall 26.4 per 100 person-year observations (95% CI: 23.46, 30.74) incidence rate of anemia. According to the multivariable Cox regression, TB co-infection (AHR =1.99, 95% CI: 1.45, 2.74), zidovudine-based regimen (AHR=1.39, 95CI: 1.1, 1.85), CD4 level (AHR= 1.7, 95% CI: 1.23, 2.35), advanced WHO stage (AHR=1.32, 95% CI: 1.01, 1.74), and being underweight (AHR= 1.53, 95% CI: 1.14, 2.07) were predictors of anemia.
CONCLUSION: Anemia is a burden among HIV patients in the study setting. Baseline clinical variables, TB co-infection, and zidovudine-based were predictors of anemia. Therefore, early identification of anemia and addressing significant predictors are highly suggested to the study setting.
© 2021 Agegnehu et al.

Entities:  

Keywords:  Ethiopia; HIV; anemia incidence; first-line HAART

Year:  2021        PMID: 33958896      PMCID: PMC8096420          DOI: 10.2147/HIV.S280338

Source DB:  PubMed          Journal:  HIV AIDS (Auckl)        ISSN: 1179-1373


  32 in total

1.  HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.

Authors:  Asfaw Adane; Kassu Desta; Aknanaw Bezabih; Anteneh Gashaye; Desta Kassa
Journal:  Ethiop Med J       Date:  2012-01

2.  Haematologic manifestations of the human immune deficiency virus (HIV).

Authors:  L I Zon; C Arkin; J E Groopman
Journal:  Br J Haematol       Date:  1987-06       Impact factor: 6.998

3.  Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.

Authors:  Zibusiso Ndlovu; Tobias Chirwa; Simbarashe Takuva
Journal:  Pan Afr Med J       Date:  2014-10-01

4.  Factors Associated with Anemia among People Living with HIV/AIDS Taking ART in Ethiopia.

Authors:  Ketema Bizuwork Gebremedhin; Tadesse Bedada Haye
Journal:  Adv Hematol       Date:  2019-03-03

5.  INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA.

Authors:  N Y Ikunaiye; B A Denue; B A Aina; R Aderemi-Williams; H E Rawizza
Journal:  Ann Ib Postgrad Med       Date:  2018-12

6.  Prevalence and associated factors of anemia among adult human immune deficiency virus positive patients on anti-retroviral therapy at Debre tabor Hospital, Northwest Ethiopia.

Authors:  Kassaw Wubneh Zerihun; Gashaw Andargie Bikis; Esmael Ali Muhammad
Journal:  BMC Res Notes       Date:  2019-03-25

Review 7.  Malnutrition and infection: complex mechanisms and global impacts.

Authors:  Ulrich E Schaible; Stefan H E Kaufmann
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

8.  Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen.

Authors:  Simbarashe Takuva; Mhairi Maskew; Alana T Brennan; Ian Sanne; A Patrick Macphail; Mathew P Fox
Journal:  J Trop Med       Date:  2013-08-27

9.  Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.

Authors:  Lealem Gedefaw; Tilahun Yemane; Zewdineh Sahlemariam; Daniel Yilma
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study.

Authors:  Bamlaku Enawgaw; Meseret Alem; Zelalem Addis; Mulugeta Melku
Journal:  BMC Hematol       Date:  2014-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.